In-house biomarker discovery
OGT has active in-house discovery programmes in a number of different cancers and auto-immune disorders.
Find out more
For more information about any OGT product or service, please contact us.
Overview
OGT’s in-house biomarker discovery programmes utilise high-throughput processing and analytical capabilities to identify and validate informative biomarkers for a range of diseases. These internal programmes are at various stages in the development process (Figure 1). OGT will develop and commercialise these tests through a combination of internal development and external partnering. In addition to these discovery projects, OGT has ongoing partnerships within tumour profiling and companion diagnostics.
Figure 1: OGT's internal biomarker discovery programmes.